Skip to content

Role and mechanism of NK cells in acute pancreatitis reaggravation and translocation of infection

Role and mechanism of NK cells in acute pancreatitis reaggravation and translocation of infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095370
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-02-13
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Sponsors

Hunan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 70 years of age 2. Within 48 hours of onset 3. Have a preliminary diagnosis of AP; meet 2 of the following 3 criteria: 1) have abdominal pain characteristic of acute pancreas; 2) have serum amylase and/or lipase 3 times more than the upper limit of normal; 3) have imaging manifestations characteristic of acute pancreatitis.

Exclusion criteria

Exclusion criteria: 1. family members of investigators directly involved in the trial 2. patients with a known history of severe cardiovascular, respiratory, renal, or hepatic disease, defined as (1) class II or greater heart failure, (2) active myocardial ischemia or (3) previous cardiovascular intervention within 60 days, (4) a history of cirrhosis of the liver, or (5) chronic renal disease with a creatinine clearance of <40 mL/min, or (6) pre-existing diseases such as chronic obstructive pulmonary disease (COPD), HIV/AIDS, etc. Patients with pre-existing immunologic diseases such as AIDS 3. pregnancy pancreatitis, history of chronic pancreatitis, malignancy-related AP 4. patients who, in the opinion of the investigator, are not justified for inclusion, e.g., patients expected to die within 48 hours of enrollment 5. transfer from a lower level hospital where the onset of illness has exceeded 48 hours

Design outcomes

Primary

MeasureTime frame
Number of NK cells;NK cell function;NK cell metabolism;Neutrophil count;Mitochondrial function;

Secondary

MeasureTime frame
CXCL-1;IL-10;IL-17;TGF-ß1;TNF-a;IL-1;IL-6;IL-8;

Countries

China

Contacts

Public ContactTan Chaochao

Hunan Provincial People's Hospital

tchchwolf@163.com+86 135 4964 3436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026